Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piracetam for Aphasia in Acute Ischemic MCA Stroke
NCT01883011Phase 4Terminated
- Sponsor
- UCB
- Start
- Aug 1998
- Primary completion
- Jul 2001
- Modality
- Small Molecules
- Countries
- 15
01
Overview
Phase 4, randomised, double-blind trial in ischemic stroke comparing Piracetam with Placebo (2 arms). Primary endpoint: Frenchay Aphasia Screening Test at Day 84. Started Aug 1998; status: terminated.
02
Drugs
piracetam
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01883011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01883011.